Researchers at the Universities of York and Leiden have pioneered a technique which uses florescent imaging to track the actions of key enzymes in cancer, genetic disorders and kidney disease.
Scientists hope this new development will aid drug design for new anti-cancer, inflammation and kidney disease treatments.
It will also provide diagnostic tools for disease identification and allow medical professionals to measure the effectiveness of drug treatment regimes in an easy laboratory manner.
Studying heparanase – a key enzyme in the development and metastasis of human cancers – scientists unveiled new fluorescent imaging agents that detect enzyme activity in healthy and diseased tissues.
The research, published this week in Nature Chemical Biology, builds upon previous work revealing heparanase’s three-dimensional structure.
Heparanase is a long-studied protein in human tissues involved in breaking down the complex sugars of the “extracellular matrix” – the material surrounding cells that provides structure and stability.
Heparanase dysfunction is linked to the spread of cancers both through the breakdown of this matrix and via the subsequent release of “growth factors” – chemicals that promote tumour development.
Through its remodelling of the matrix, heparanase is also a key player in inflammation and kidney disease. It is therefore a major drug, and diagnostic probe, target.
Early disease identification
Gideon Davies, Professor of Structural Enzymology and Carbohydrate Chemistry at the University of York, said: “Heparanase is a key human enzyme. Its dysregulation is involved in inherited genetic disorders, and it is also a major anti-cancer target and increasingly implicated in kidney disease.
“Our work allows us to probe the activity of heparanase in human samples – allowing early disease identification and a direct measure of the success of drugs in humans.
“This work is a great example of the power of EU collaboration and science funding from the European Research Council.”
Hermen Overkleeft, Professor of Bio-Organic Synthesis at Leiden University, added: “This work reveals the power of activity-based protein profiling: the probe described here at once enables screening for heparanase inhibitors from large compound collections and is a lead compound for drug development in its own right.
“While the road to heparanase-targeting clinical drugs is long and fraught with risks, with this work we believe to have taken a major step in realising the therapeutic potential of this promising clinical target.”
The Latest on: Florescent imaging
- Correlative light and scanning electron microscopy (CLSEM) for analysis of bacterial infection of polarized epithelial cellson November 19, 2019 at 8:39 am
Using landmarks in the grid centre for orientation, areas of up to 200 µm² can be chosen as ROI in live cell imaging by simply counting holes of the mesh grid. After EM sample preparation, gold mesh ...
- Medexus Granted Priority Review Status for Gliolan(R) by Health Canadaon November 19, 2019 at 4:30 am
Gliolan(R) assists neurosurgeons to better visualize and more completely remove gliomas by causing them to become fluorescent and glow during surgery ... There are currently no optical imaging agents ...
- New imaging technique unlocks secrets of the zebrafish hearton November 15, 2019 at 6:32 am
The development of the imaging breakthrough was led by Dr. Jonathan Taylor of the University of Glasgow's School of Physics and Astronomy, working closely with colleagues at the University of ...
- Deep-UV excitation fluorescence microscopy for detection of lymph node metastasis using deep neural networkon November 15, 2019 at 2:12 am
We established a fluorescent staining protocol for DUV excitation fluorescence imaging that has enabled clear discrimination of nucleoplasm, nucleolus, and cytoplasm. Fluorescence images of metastasis ...
- eBook: Simple as a Selfie: One-Button Scientific Imagingon November 14, 2019 at 11:49 pm
Different experiments call for different visualization techniques, ranging from chemiluminescent antibodies for protein assays to laser-guided live animal whole-body fluorescent imaging. Technological ...
via Google News and Bing News